Apyx Medical Corporation Reports Fourth Quarter and Full Year 2024 Financial Results
Provided By GlobeNewswire
Last update: Mar 13, 2025
CLEARWATER, Fla., March 13, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency platform technology marketed and sold as Renuvion®, today reported the financial results for its fourth quarter and year ended December 31, 2024.
Read more at globenewswire.com
